Promoting integration of pharmacy expertise in care of hospitalized patients with acute myocardial infarction

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Leslie A CurryMarie Smith

Abstract

The substantive integration of pharmacists into quality-improvement initiatives aimed at improving the care of hospitalized patients with acute myocardial infarction (AMI) is described. A 2-year, mixed-methods, interventional study was conducted in 10 U.S. hospitals, directed at promoting the use of evidence-based strategies and fostering domains of hospital organizational culture associated with lower risk-standardized mortality rates (RSMRs) for patients with AMI. The adoption of 5 evidence-based strategies associated with reducing RSMRs for AMI was measured at baseline, 12, and 24 months. Data were collected via face-to-face interviews conducted at each hospital. Ethnographic observations were conducted at baseline and 18 months. Significant changes in the use of evidence-based strategies were observed over the 2-year study period (p = 0.02), with the mean number of strategies used per hospital increasing from 2.4 at baseline to 3.9 at 24 months. Innovative approaches for integrating pharmacotherapy and pharmacy practice expertise included information technology solutions, targeted rounding for patients with AMI, medication-bridging programs, and education of patients with AMI. A mixed-methods interventional study in 10 hosp...Continue Reading

References

Jul 28, 1999·JAMA : the Journal of the American Medical Association·L L LeapeD W Bates
Jun 20, 2003·The Journal of Applied Psychology·J Stuart Bunderson, Kathleen M Sutcliffe
Jan 23, 2004·The Journal of Nursing Administration·Robyn R M GershonElaine Larson
May 10, 2006·Archives of Internal Medicine·Peter J KaboliJeffrey L Schnipper
Aug 10, 2006·The Annals of Pharmacotherapy·Kelly A GrindrodJanet E Martin
Mar 27, 2007·Pharmacotherapy·C A Bond, Cynthia L Raehl
Dec 14, 2007·Health Care Management Review·Carol VanDeusen LukasMartin P Charns
Jun 11, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Thomas De RijdtSteven Simoens
Sep 21, 2010·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Marie A Chisholm-BurnsJohn Palmer
Mar 16, 2011·Annals of Internal Medicine·Leslie A CurryElizabeth H Bradley
May 2, 2012·Annals of Internal Medicine·Elizabeth H BradleyHarlan M Krumholz
Jan 1, 2014·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Bruce A WardenJohn Mackay
Jan 18, 2015·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Kelly A Green BoesenRobert Sobolik
Apr 19, 2015·Implementation Science : IS·Leslie A CurryElizabeth H Bradley
May 26, 2015·Journal of the Chinese Medical Association : JCMA·Wen-Ling LeePeng-Hui Wang
Oct 6, 2015·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Arti PhatakMichael Postelnick
Nov 7, 2015·Journal of the American College of Cardiology·Steven P DunnMary Norine Walsh
Feb 18, 2016·Journal of General Internal Medicine·Susan P BellUNKNOWN Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) Study Group

❮ Previous
Next ❯

Citations

Nov 6, 2018·Health Affairs·Rebecca Gale
Sep 13, 2019·Circulation. Cardiovascular Quality and Outcomes·Colleen K McIlvennanLeslie Curry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.